Petalmed Pharma

Temozolomide 250 mg Capsules are an oral chemotherapy medication used primarily in the treatment of certain types of brain tumors. The active ingredient, Temozolomide, is an alkylating agent that works by interfering with the DNA of cancer cells, preventing their growth and replication.
This medication is commonly prescribed for the treatment of glioblastoma multiforme and anaplastic astrocytoma, either as first-line therapy in combination with radiotherapy or as maintenance therapy after initial treatment.
Each capsule contains 250 mg of Temozolomide and is manufactured under strict pharmaceutical quality standards to ensure safety, efficacy, and consistency.